Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R7AG
|
|||
| Former ID |
DNC005224
|
|||
| Drug Name |
4-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H9NO4
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1O)O)C2=NC3=C(O2)C=CC(=C3)O
|
|||
| InChI |
1S/C13H9NO4/c15-7-2-4-12-10(5-7)14-13(18-12)9-3-1-8(16)6-11(9)17/h1-6,15-17H
|
|||
| InChIKey |
RGXSSCFRVTXICH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J Med Chem. 2004 Oct 7;47(21):5021-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.